Healthcare just did something we said it hadn't done since 98. >> Yeah. >> 100% of the XLV sector stocks advanced on Friday.>> Yeah. >> It's happened only 34 other days going back to the inception of it >> since 98. >> You ever hear that term probably from May bread thrust like that's what that is basically but on a sector basis.It just tells you the level of instit institutional accumulation coming in. 21% of all the components in the XLV made a 52- week high on Friday. They are buying these names and ther ...

Key Points Management has high hopes for i3 Verticals' shift to a primarily software-as-a-service (SaaS) business model. Impatient investors are selling. 10 stocks we like better than I3 Verticals › Shares of i3 Verticals (NASDAQ: IIIV) sank on Monday after the software maker issued a conservative growth forecast for the year ahead. As of 3:30 p.m. EST, i3 Verticals' stock price was down more than 10% after declining as much as 24% earlier in the day. Image source: Getty Images. A shift toward s ...

Paul Christians: Thank you, Rick. i3 Verticals, Inc. is structured into five primary markets: Justice tech, transportation, public administration, education, and utilities. Because we intentionally structured our organization in a market-centric model to remain as close to the customer as possible, intra-market cross-selling naturally progressed into solution bundling. As solutions have evolved, some are applicable cross-market. Given that, leadership is actively identifying synergistic opportunities across ...

Financial Data and Key Metrics Changes - In Q3 2025, the company's revenue was $2 million, a 24% decrease from $2.5 million in Q3 2024, primarily due to a timing reduction in iHP services sales from a key customer [9][10] - Year-to-date service demand remains robust, with quote activity and pipeline volume up approximately 35% year-over-year in life sciences and food safety [10] - Gross profit margins remained strong at 61% for Q3 2025, consistent with the same period last year [10] Business Line Data and Key Metrics Changes - Recurring BIT solution sales increased by 21% year-to-date, contributing to the overall revenue growth [5][10] - The sales order backlog was $0.9 million at the quarter end and grew to $1.3 million by October 31, with approximately $3 million in pending SteraMist integration contracts expected to close before year-end [6][10] Market Data and Key Metrics Changes - The FDA's broadened approval of hydrogen peroxide positions the company to serve not only life sciences and healthcare but also agriculture, food processing, and environmental biosafety [7][23] - The active pipeline surpassed $15 million, encompassing both domestic and international customers across various industries [6] Company Strategy and Development Direction - The company aims to enhance customer engagement and expand its recurring revenue streams through personalized outreach and targeted marketing campaigns [8] - Focus on biosecurity advancements and scaling automation integrations for high-efficacy environments is prioritized for 2026 [8][9] - The company is investing in innovation and customer success to capture opportunities in clean tech and biosecurity [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's recovery and reaffirmed the soundness of its strategy, with steady improvement expected financially, operationally, and strategically [25][26] - The company is well-positioned for a successful fourth quarter with momentum carrying into 2026, supported by a recent equity purchase agreement to access capital [26][27] Other Important Information - The company celebrated a significant addition to its customer roster with Bausch + Lomb, which adopted mobile handheld surface units and committed to BIT Solution orders for 2026 [19][20] - The company is actively pursuing the cannabis market and has opened doors to promising new partnership discussions [22] Q&A Session Summary Question: What are your sales and marketing efforts towards the FDA approval for hydrogen peroxide usage? - Management indicated that the food industry could be a key marketing vertical, and they are excited about the approval as it positions their technology favorably [29] Question: Should we expect operating expenses and gross margins to continue improving? - Management expects operating expenses to increase but remain positive in relation to revenue, with gross margins expected to hold steady [30][31] Question: What kind of sales effort is in place for international markets like Morocco? - The company has distributors in various countries and is working with global partners to increase demand for SteraMist [34] Question: Do you have visibility on solution sales in the coming quarters? - Management noted that while there was a decrease in solution sales growth in Q3, they expect a rebound by the end of the fourth quarter [35] Question: Any updates on servicing military and defense markets? - Management mentioned ongoing studies with a key site looking to replace formaldehyde, with expectations for significant developments in 2026 [42] Question: Any progress in the use of SteraMist for replacing ethylene oxide in medical sterilization? - Management confirmed ongoing discussions and prioritization of partnerships in device manufacturing for this purpose [51]

Financial Data and Key Metrics Changes - In Q3 2025, the company's revenue was $2 million, a 24% decrease from $2.5 million in Q3 2024, primarily due to a timing reduction in IHP services sales from a key customer [9][10] - Year-to-date service demand remains robust, with quote activity and pipeline volume up approximately 35% year over year in the life sciences and food safety areas [10] - Gross profit margins remained strong at 61% for Q3 2025, consistent with the same period last year [10] Business Line Data and Key Metrics Changes - Recurring BIP solution sales increased by 21% year to date, indicating a positive trend in this segment [5][10] - The sales order backlog was $0.9 million at the quarter end and grew to $1.3 million by October 31, with approximately $3 million in pending SteraMist integration contracts expected to close before year-end [6][10] Market Data and Key Metrics Changes - The FDA's broadened approval of hydrogen peroxide as a safe disinfectant opens new markets, particularly in food safety, agriculture, and environmental biosafety [7][23] - The company is seeing strong interest from emerging sectors, with an active pipeline surpassing $15 million [6] Company Strategy and Development Direction - The company aims to grow sales of mobile capital equipment, IHP corporate service, and custom integration platforms alongside its core BIP solution business model [5] - There is a focus on biosecurity advancements and scaling automation integrations for high-efficacy environments, addressing global challenges [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's recovery and strategic execution, highlighting steady improvement financially, operationally, and strategically [25] - The company is well-positioned for a successful fourth quarter with momentum carrying into 2026, supported by a recent equity purchase agreement to access capital [26] Other Important Information - The company has been recognized as the Disinfection and Decontamination Products Company of the Year 2025, validating its solutions and positioning [7] - The company is expanding its training programs and customer engagement strategies to enhance market penetration [8] Q&A Session Summary Question: What are the sales and marketing efforts towards the FDA approval for hydrogen peroxide? - Management indicated that the food industry could be a key marketing vertical, and they are excited about the approval as it positions their technology favorably [30] Question: Should we expect operating expenses and gross margins to continue improving? - Management expects operating expenses to increase but remain positive in relation to revenue, with gross margins holding steady [31][32] Question: What kind of sales effort is in place for international markets like Morocco? - The company has distributors in various countries focused on increasing demand for SteraMist [36] Question: Do you have visibility on solution sales in the coming quarters? - Management noted that while they had a 40% increase in solution sales earlier in the year, they expect recurring sales to rise again by the end of Q4 [37] Question: Any updates on servicing military and defense markets? - Management mentioned ongoing studies with a key site looking to replace formaldehyde, expecting significant developments in 2026 [43] Question: Progress on CAR T-cell disinfection business? - No updates were provided on this front [45] Question: Expectations on the rollout by major service provider companies in healthcare mold remediation? - Management expressed optimism about rapid rollouts due to strong initial assessments and training support [46] Question: Plans to penetrate the disinfection market for data centers? - Management acknowledged the interest in data centers and the need for disinfection, indicating plans to expand the sales team for this vertical [49] Question: How is the company increasing awareness for the food industry post-FDA ruling? - The company is focusing on social media and reaching out to existing contacts in the food safety sector [51] Question: Any progress in using SteraMist for replacing ethylene oxide in medical sterilization? - Management confirmed ongoing discussions and prioritization of partnerships in this area [54]

Core Insights - ONNIT, a health and wellness brand owned by Unilever, successfully migrated its subscriber base to Ordergroove and Shopify with a 99.6% success rate and no downtime [1][2] Group 1: Technology Integration - The integration of Ordergroove and Shopify provides ONNIT with a scalable tech stack that enhances its subscription model and allows for profitable recurring revenue [2][4] - This new tech foundation enables ONNIT to implement data-driven strategies, such as prepaid models and A/B-tested promotions, which aim to boost customer lifetime value [4][5] - The migration reflects a broader trend among enterprise brands moving away from custom-built systems to integrated platforms that support efficient scaling and profitable growth [6] Group 2: Customer Experience and Growth Strategy - ONNIT has revamped its brand experience with a focus on conversion-oriented user experience, making subscriptions central to its growth strategy [3][4] - The new system allows ONNIT to enhance customer experiences by providing more flexibility and personalized options, thereby fostering long-term relationships and loyalty [5][6] - The partnership with Ordergroove exemplifies how leading brands are prioritizing customer experience as a key driver of growth [6] Group 3: Industry Context - Ordergroove is recognized as a market leader in subscription technology, enabling brands to shift from one-time transactions to profitable recurring relationships [8] - The collaboration between ONNIT, Ordergroove, and Shopify highlights the importance of leveraging advanced technology to meet evolving consumer demands in the subscription economy [6][8]

Financial Data and Key Metrics Changes - Consolidated revenue for Q3 2025 increased by 3% year over year to $841 million [4] - Adjusted EBITDA grew 18% year over year to $375 million, with a record margin expansion across all three businesses [4][22] - Adjusted EPS increased by 35% year over year to $1.81 [4][22] - Net income rose by 78% year over year, with diluted net income per share increasing by 89% to $1.34 [22] Business Line Data and Key Metrics Changes - Gaming revenue increased by 38% year over year to $241 million, driven by strong gaming operations performance and contributions from Grover [9][22] - Recurring revenue grew by 14% year over year, accounting for approximately 69% of consolidated revenue [5][22] - iGaming revenue reached a record $86 million, up 16% year over year, with Adjusted EBITDA increasing by 42% to $34 million [17][22] Market Data and Key Metrics Changes - North American gaming machine sales remained strong with over 6,000 units shipped in the quarter [12] - The average daily revenue per unit in North America increased by 5% year over year, excluding Grover units [11] - The company entered the Nebraska Skill Game market and commenced trials in the Eastern European Dynamic Multi-game market [12] Company Strategy and Development Direction - The company is transitioning to a sole standard listing on the ASX, expected to enhance its profile in the gaming industry [5][6] - Focus remains on the integration of Grover into game development and technology platforms, with expectations for significant contributions in 2026 [6][39] - The company emphasizes a disciplined capital allocation strategy to create sustainable shareholder value [8][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver growth and profitability despite broader market challenges [20] - The gaming consumer market remains resilient, with expectations for continued strong performance in the fourth quarter [44] - Management highlighted the importance of not compromising long-term growth for short-term goals, focusing on quality earnings [37] Other Important Information - The company returned $111 million to shareholders through share repurchases during the quarter [5][30] - Operating cash flows generated in the quarter amounted to $184 million, with free cash flow increasing by 64% year over year to $136 million [26] - The company maintains a net debt leverage ratio of 3.3 times following the Grover acquisition [28] Q&A Session Summary Question: How does the company see the fourth quarter shaping up to hit 2025 guidance? - Management highlighted strong U.S. sales and contributions from Grover, indicating a predictable earnings outlook for Q4 [34][35] Question: Can you provide an update on Grover's integration and Indiana launch? - Grover added 229 games in the quarter, with successful integration into the Light & Wonder family and preparations for the Indiana market entry [38][39] Question: What drove the gaming margin improvement in Q3? - The gaming operations business saw significant growth, contributing to margin expansion, with expectations for continued momentum [40][41] Question: What is the outlook for iGaming and SciPlay? - iGaming showed strong growth driven by first-party content, while SciPlay is focused on stabilizing mature games like Jackpot Party to return to growth [53][48][59]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Insights - Aware, Inc. (AWRE) has experienced a stock decline of 7.4% since its earnings report for the year ended September 30, 2025, underperforming the S&P 500 Index's 0.3% decline during the same period [1] - The company reported a revenue increase of 33.3% year over year for Q3 2025, driven by license sales, despite a net loss of $1.1 million [2][10] Financial Performance - Q3 2025 revenues reached $5.1 million, up from $3.8 million in Q3 2024, with a notable contribution from a $1 million expansion in perpetual license sales [2] - The net loss improved to $1.1 million, or $(0.05) per diluted share, compared to a loss of $1.2 million, or $(0.06) per share, a year earlier [2] - Adjusted EBITDA loss narrowed to $0.8 million from $1.1 million year over year, reflecting revenue growth and cost discipline [3] Operating Expenses - Operating expenses increased by 20.8% to $6.4 million, primarily due to investments in sales, marketing, and product development [3] - Research and development costs rose 13.8% to $2.1 million, while selling and marketing expenses increased 13.3% to $2.1 million [4] Revenue Breakdown - Recurring revenue grew to $3.6 million, representing 69.3% of total Q3 2025 revenue, a 26.2% increase from the previous year [6] - Non-recurring revenue increased by 52.7% to $1.6 million, with software license revenue jumping 118.7% year over year [7] Cash Position - Cash, cash equivalents, and marketable securities totaled $22.5 million as of September 30, 2025, down from $27.8 million at year-end 2024 [7] Strategic Initiatives - The CEO highlighted a transformation strategy focused on advancing technology, enhancing customer engagement, and building strategic partnerships [8] - Aware achieved FIDO Alliance Certification for its face verification technology, positioning the company favorably in the biometric solutions market [9] Market Demand - The revenue increase was attributed to expanding government deployments and rising commercial demand for biometric solutions amid heightened cybersecurity needs [9] - The Chief Revenue Officer noted growing demand across federal and commercial sectors, particularly within DHS programs [11] Future Outlook - Management did not provide formal quantitative guidance but emphasized a focus on large, durable opportunities that can evolve into multi-year recurring revenue streams [12] - The company is prioritizing certifications such as ISO and FedRAMP, which are essential for federal and enterprise contracts [14]

Financial Data and Key Metrics Changes - For Q3 2025, the company reported a 63% increase in revenue and a 130% increase in net income compared to Q3 2024 [5] - Residential real estate revenue grew by 94% to $36.8 million from $19 million, with the average homesite base price increasing to $150,000 from $86,000 and gross margin rising to 53% from 39% [5] - Recurring revenue from leasing increased by 7% to a record $16.7 million, while hospitality revenue rose by 9% to a record $60.6 million for the third quarter [5][6] Business Line Data and Key Metrics Changes - The company executed 40 new commercial leases and renewed 43 existing leases for a total of 83 during the first nine months of 2025, compared to 53 during the same period in 2024 [6] - At the end of Q3 2025, there were 1,992 residential units under contract, up from 1,381 in the same period in 2024 [6] - The company has over 24,000 entitled units in its residential pipeline across various stages of planning, engineering, permitting, or development [6] Market Data and Key Metrics Changes - The sale of Watercress Senior Living for $41 million resulted in a gross profit of $19.4 million, demonstrating the company's ability to monetize developed properties [7] - The company is leveraging new nonstop flights between Northwest Florida Beaches International Airport and LaGuardia Airport to expand marketing efforts to a larger population base [10][11] Company Strategy and Development Direction - The company plans to continue creating asset value by developing operating properties for recurring revenue or monetizing them for capital allocation [8] - A measured and multifaceted capital allocation strategy was executed, with $20.4 million for capital expenditures, $8.7 million for share repurchase, $8.1 million for cash dividends, and $28.4 million for project debt reduction [9] - The company is focused on strategic timberlands for monetization opportunities while ensuring that assets are not sold at a discount [17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's cash generation capabilities and emphasized the importance of maintaining liquidity while executing a capital allocation strategy [13][21] - The company is optimistic about the growth potential in the region, particularly with the establishment of an academic health center and increased direct flights to major metropolitan areas [55][56] Other Important Information - The company announced a 14% increase in the quarterly dividend to $0.16 per share, marking a 129% increase in dividend payments since the program's inception in 2020 [10] - The outstanding share balance is now below 58 million for the first time in nearly 30 years, reflecting significant share repurchase activity [10] Q&A Session Summary Question: Why is the company building cash rather than increasing the pace of buybacks? - Management highlighted the positive cash generation and emphasized that share repurchase remains a priority within their capital allocation strategy [12][13] Question: Why not sell more assets at values that are material relative to the current market cap? - Management stated that they are evaluating assets for monetization but will not sell at a discount, ensuring that shareholders receive fair value [15][17] Question: What are the expected cash levels in 12 to 18 months? - Management indicated that future cash levels will depend on various factors, including macroeconomic conditions and the company's capital allocation strategy [18][21] Question: Any updates on talks with a large-scale builder for Pigeon Creek DSAP? - Management confirmed that discussions are ongoing but did not provide specific updates [22] Question: What is the current value of the company's land inventory? - Management mentioned that a third-party valuation of operating properties was provided at the annual meeting, and similar evaluations for timberlands are in process [42] Question: How does the company view pricing and discounting? - Management clarified that they have not been discounting home site pricing and maintain a consistent pricing strategy across residential communities [51][53]